Pacific Center for Financial Services’s Moderna MRNA Stock Holding History

Pacific Center for Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68K	Hold	24	–	–	﹤0.01%	439
2026 Q1	$1.22K	Hold	24	–	–	﹤0.01%	455
2025 Q4	$620	Hold	24	–	–	﹤0.01%	445
2025 Q3	$620	Hold	24	–	–	﹤0.01%	445
2025 Q2	$663	Hold	24	–	–	﹤0.01%	432
2025 Q1	$681	Hold	24	–	–	﹤0.01%	437
2024 Q4	$1K	Hold	24	–	–	﹤0.01%	434
2024 Q3	$1.61K	Hold	24	–	–	﹤0.01%	413
2024 Q2	$2.86K	Hold	24	–	–	﹤0.01%	391
2024 Q1	$2.56K	Hold	24	–	–	﹤0.01%	399
2023 Q4	$2.39K	Hold	24	–	–	﹤0.01%	339
2023 Q3	$2.49K	Hold	24	–	–	﹤0.01%	354
2023 Q2	$2.92K	Hold	24	–	–	﹤0.01%	339
2023 Q1	$3.7K	Buy	+24	New	+$3.96K	﹤0.01%	329
2022 Q3	$3K	Hold	24	–	–	﹤0.01%	346
2022 Q2	$3K	Hold	24	–	–	﹤0.01%	347
2022 Q1	$4K	Hold	24	–	–	﹤0.01%	332
2021 Q4	$6K	Hold	24	–	–	﹤0.01%	315
2021 Q3	$9K	Buy	+24	New	+$8.85K	﹤0.01%	297

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Pacific Center for Financial Services's MRNA Position: Q2 2026 in Review

Pacific Center for Financial Services held its Moderna (MRNA) position steady in Q2 2026 at 24 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Pacific Center for Financial Services first reported a position in MRNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $9K in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Pacific Center for Financial Services held 24 shares of Moderna worth $1.68K as of Q2 2026.
Pacific Center for Financial Services left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #439 holding.
Pacific Center for Financial Services first reported a position in Moderna in Q3 2021 and has held it in 19 quarters since.
Pacific Center for Financial Services's Moderna position peaked at $9K in Q3 2021.
780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.